Literature DB >> 12818202

Staying straight with A-tracts: a DNA analog of the HIV-1 polypurine tract.

Marie L Coté1, Mark Pflomm, Millie M Georgiadis.   

Abstract

The polypurine tract (PPT) from the HIV-1 genome is resistant to digestion by reverse transcriptase following (-)-strand synthesis and is used to prime (+)-strand synthesis during retroviral replication. We have determined the crystal structure of the asymmetric DNA/DNA analog16-mer duplex (CTTTTTAAAAGAAAAG/CTTTTCTTTTAAAAAG) comprising most of the "visible" portion of the RNA:DNA hybrid from the polypurine tract of HIV-1, which was previously reported in a complex with HIV-1 reverse transcriptase. Our 16-mer completely encompasses a 10-mer DNA duplex analog of the HIV-1 PPT. We report here a detailed analysis of our B' form 16-mer DNA structure, including three full pure A-tracts, as well as a comparative structural analysis with polypurine tract and other A-tract-containing nucleic acid structures. Our analysis reveals that the polypurine tract structures share structural features despite being different nucleic acid forms (i.e. DNA:DNA versus RNA:DNA). In addition, the previously reported A-tract-containing DNA molecules bound to topoisomerase I are remarkably similar to our polypurine tract 16-mer structure. On the basis of our analysis, we suggest that the specific topology of long pure A-tracts is remarkably comparable across a wide array of biological environments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818202     DOI: 10.1016/s0022-2836(03)00554-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase.

Authors:  Jeffrey J DeStefano; Gauri R Nair
Journal:  Oligonucleotides       Date:  2008-06

Review 2.  Toward an Expanded Genome: Structural and Computational Characterization of an Artificially Expanded Genetic Information System.

Authors:  Nigel G J Richards; Millie M Georgiadis
Journal:  Acc Chem Res       Date:  2017-06-08       Impact factor: 22.384

3.  A high-throughput, high-resolution strategy for the study of site-selective DNA binding agents: analysis of a "highly twisted" benzimidazole-diamidine.

Authors:  Kristie D Goodwin; Mark A Lewis; Farial A Tanious; Richard R Tidwell; W David Wilson; Millie M Georgiadis; Eric C Long
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

4.  Crystal structure of a trypanocidal 4,4'-bis(imidazolinylamino)diphenylamine bound to DNA.

Authors:  LaTeca S Glass; Binh Nguyen; Kristie D Goodwin; Christophe Dardonville; W David Wilson; Eric C Long; Millie M Georgiadis
Journal:  Biochemistry       Date:  2009-06-30       Impact factor: 3.162

5.  A host-guest approach for determining drug-DNA interactions: an example using netropsin.

Authors:  Kristie D Goodwin; Eric C Long; Millie M Georgiadis
Journal:  Nucleic Acids Res       Date:  2005-07-27       Impact factor: 16.971

6.  Crystal structures of oligonucleotides including the integrase processing site of the Moloney murine leukemia virus.

Authors:  Sherwin P Montaño; Marie L Coté; Monica J Roth; Millie M Georgiadis
Journal:  Nucleic Acids Res       Date:  2006-09-26       Impact factor: 16.971

7.  Consecutive non-natural PZ nucleobase pairs in DNA impact helical structure as seen in 50 μs molecular dynamics simulations.

Authors:  Robert W Molt; Millie M Georgiadis; Nigel G J Richards
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

8.  Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract.

Authors:  Gauri R Nair; Chandravanu Dash; Stuart F J Le Grice; Jeffrey J DeStefano
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  The structure of an authentic spore photoproduct lesion in DNA suggests a basis for recognition.

Authors:  Isha Singh; Yajun Jian; Yajun Lian; Lei Li; Millie M Georgiadis
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.